CDCody Garett Durrer

Cody Garett Durrer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cody Garett Durrer has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    (Dis)agreement and concordance of metabolic indices from the oral glucose tolerance test and mixed‐meal tolerance test: Implications for application

    by Nina Sloth Nielsen, Nikolaj Agerlin, Nikolas Antoniou, Helga Ellingsgaard, Kristian Karstoft, Louise Lang Lehrskov, Grit Elster Legård, Mark Preben Printz Lyngbæk, Beckey Trinh, Thomas P. J. Solomon, et al.

    Metabolic indices derived from the oral glucose tolerance test (OGTT) and mixed‐meal tolerance test (MMTT) are often interpreted interchangeably; however, these tests represent distinct physiological stimuli. In order to examine potential differential metabolic responses to these tests, we characterized the (dis)agreement between OGTT‐ and MMTT‐derived indices of insulin sensitivity, insulin secretion and β‐cell function. We also described their convergent validity in individuals with normal glucose tolerance (NGT) or type 2 diabetes (T2D). We conducted a post hoc analysis of eight trials with participants who underwent either OGTT or MMTT, or both. Insulin sensitivity, insulin secretion and β‐cell function were derived. Agreement was assessed using Bland–Altman regression approaches to estimate systematic and proportional bias and 95% limits of agreement. Linear mixed‐effects models were used to estimate means by glycaemic status (NGT vs. T2D), and area under the receiver operating characteristic (AUROC) curve analyses were used to evaluate discriminative ability between glycaemic status for the respective test indices. No systematic bias was observed. Proportional bias was present for insulin secretion and β‐cell function, with increasingly negative differences between methods (OGTT–MMTT) as outcome values increased. All indices exhibited relatively wide 95% limits of agreement, which widened further at higher magnitudes. The OGTT‐ and MMTT‐derived means were significantly different between NGT and T2D. We did not observe differences in AUROC between tolerance tests. Agreement between OGTT‐ and MMTT‐derived indices worsened as the respective value increased, suggesting differential stimulus–response characteristics in insulin secretion between tolerance tests. Despite this, descriptive analyses suggest that the test‐specific indices demonstrate convergent validity.

  • Open Access

    Body Fluid Proteomic Landscape of Acute Exercise

    by Nigel Kurgan, Jeppe Kjærgaard, Naja Zenius Jespersen, Viriginia Díez-Obrero, Roger Moreno-Justicia, Sarah Elizabeth Heywood, Cecilie Bergmann Lindqvist, Lisa Ottander, Diana Samodova-Sommer, Nina Sloth Nielsen, et al.

    Physical activity improves health, yet the molecular mechanisms remain partially understood. This study presents a high-resolution, time-resolved atlas profiling 10,127 proteins across plasma, saliva, and urine from healthy adults post-acute exercise. Exercise regulated over 3,000 proteins, revealing distinct, fluid-specific temporal dynamics. By integrating fluid-specific exercise signatures with tissue and disease atlases, we delineated the contribution of tissues and associations to various diseases. Network analysis across body fluids elucidated coordinated remodeling in the extracellular matrix and immune activation orchestrating exercise-induced networks. Many exercise-responsive plasma proteins were robust across age, sex, and exercise modalities, indicating a conserved systemic signature. Integration with genetic data established exercise-regulated proteins as modulators of metabolic traits and identified over 200 targeted by approved drugs, highlighting their impact on disease-relevant pathways. This comprehensive atlas, available as an open-access resource cbmr.ku.dk/research/research-groups/deshmukh-group/shiny-apps/, advances our molecular insight into exercise adaptations and enables exerkine discovery, biomarker development, and pharmacological exercise-mimetic strategies.


  • Open Access

    The state of mechanistic research in the evidence‐based medicine era: A sandwalk between triangulation and hierarchies

    by Ronan M. G. Berg, Cody G. Durrer, Jan Kyrre Berg Olsen Friis, Mathias Ried‐Larsen


  • Open Access

    The whole‐body and skeletal muscle metabolic response to 14 days of highly controlled low energy availability in endurance‐trained females

    by Hannah G. Caldwell, Jan S. Jeppesen, Lone O. Lossius, Jesper P. Atti, Cody G. Durrer, Mikkel Oxfeldt, Anna K. Melin, Mette Hansen, Jens Bangsbo, Lasse Gliemann, et al.

    This study investigated the effects of 14 days low energy availability (LEA) versus optimal energy availability (OEA) in endurance‐trained females on substrate utilization, insulin sensitivity, and skeletal muscle mitochondrial oxidative capacity; and the impact of metabolic changes on exercise performance. Twelve endurance‐trained females (V̇O 2max 55.2 ± 5.1 mL × min −1 × kg −1 ) completed two 14‐day randomized, blinded, cross‐over, controlled dietary interventions: (1) OEA (51.9 ± 2.0 kcal × kg fat‐free mass (FFM) −1 × day −1 ) and (2) LEA (22.3 ± 1.5 kcal × kg FFM −1 × day −1 ), followed by 3 days OEA. Participants maintained their exercise training volume during both interventions (approx. 8 h × week −1 at 79% heart rate max). Skeletal muscle mitochondrial respiratory capacity, glycogen, and maximal activity of CS, HAD, and PFK were unaltered with LEA. 20‐min time trial endurance performance was impaired by 7.8% (Δ −16.8 W, 95% CI: −23.3 to −10.4, p < .001) which persisted following 3 days refueling post‐LEA ( p < .001). Fat utilization was increased post‐LEA as evidenced by: (1) 99.4% ( p < .001) increase in resting plasma free fatty acids (FFA); (2) 270% ( p = .007) larger reduction in FFA in response to acute exercise; and (3) 28.2% ( p = .015) increase in resting fat oxidation which persisted during submaximal exercise ( p < .001). These responses were reversed with 3 days refueling. Daily glucose control (via CGM), HOMA‐IR, HOMA‐β, were unaffected by LEA. Skeletal muscle O 2 utilization and carbohydrate availability were not limiting factors for aerobic exercise capacity and performance; therefore, whether LEA per se affects aspects of training quality/recovery requires investigation.


  • Open Access

    Impact of a 12‐week high‐intensity interval training intervention on cardiac structure and function after COVID‐19 at 12‐month follow‐up

    by Iben Elmerdahl Rasmussen, Mathilde Løk, Cody Garett Durrer, Anna Agnes Lytzen, Frederik Foged, Vera Graungaard Schelde, Josephine Bjørn Budde, Rasmus Syberg Rasmussen, Emma Fredskild Høvighoff, Villads Rasmussen, et al.

    In patients previously hospitalised for COVID‐19, a 12‐week high‐intensity interval training (HIIT) intervention has previously been shown to increase left ventricular mass (LVM) immediately after the intervention. In the present study, we examined the effects of the same HIIT scheme on LVM, pulmonary diffusing capacity, symptom severity and functional capacity at 12‐month follow‐up. In this investigator‐blinded, randomised controlled trial, 12 weeks of a supervised HIIT scheme (4 × 4 min, three times a week) was compared to standard care (control) in patients recently discharged from hospital due to COVID‐19. At inclusion and at 12‐month follow‐up, LVM was assessed by cardiac magnetic resonance imaging (cMRI, primary outcome), while pulmonary diffusing capacity for carbon monoxide ( D LCOc , secondary outcome) was examined by the single‐breath method. Symptom severity and functional status were examined by the Post‐COVID‐19 Functional Scale (PCFS) and King's Brief Interstitial Lung Disease (KBILD) questionnaire score. Of the 28 patients assessed at baseline, 22 completed cMRI at 12‐month follow‐up (12.4 ± 0.6 months after inclusion). LVM was maintained in the HIIT but not the standard care group, with a mean between‐group difference of 9.68 [95% CI: 1.72, 17.64] g ( P = 0.0182). There was no differences in change from baseline to 12‐month follow‐up between groups in D LCOc % predicted (−2.45 [−11.25, 6.34]%; P = 0.578). PCFS and KBILD improved similarly in the two groups. In individuals previously hospitalised for COVID‐19, a 12‐week supervised HIIT scheme resulted in a preserved LVM at 12‐month follow‐up but did not affect pulmonary diffusing capacity or symptom severity.


  • Open Access

    Adding Different Exercise Training Volumes to a Diet-Induced Weight Loss Facilitates Fat Loss and Maintains Fat-Free Mass in a Dose-Depending Fashion in Persons with Newly Diagnosed Type 2 Diabetes: Secondary Findings from the DOSE-EX Multi-Arm, Parallel-Group, Randomized Trial

    by Mark P.P. Lyngbæk, Grit Elster Legaard, Nina Sloth Nielsen, Cody Garrett Durrer, Thomas Peter Almdal, Morten Asp Vonsild Lund, Benedikte Liebetrau, Caroline Ewertsen, Carsten Lauridsen, Thomas P.J. Solomon, et al.

    OBJECTIVE: To assess the dose-response effects of exercise in combination with a diet-induced weight loss on fat mass (FM) percentage (FM%) in persons with diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: In this secondary analysis of a four-armed randomized trial ( Clinicaltrials.gov NCT03769883 ) 82 persons (35% females, mean age and standard deviation (SD) 58.2 (9.8) years) living with type 2 diabetes were randomly allocated to the control group (N=21, CON), diet control (25% energy restriction; N =20, DCON), diet control and exercise three times/week (two sessions of aerobic and one session combining resistance and aerobic training; N =20, MED), or diet control and exercise six times/week (four sessions of aerobic and two sessions combining resistance and aerobic training; N =21, HED) for 16 weeks. The primary outcome was the change in FM percentage points (pp). Secondary outcomes included fat-free mass and visceral adipose tissue volume. RESULTS: Type 2 diabetes duration was 4.0 years (interquartile range 1.9 to 5.5), body weight (SD) 101.4 kg (14.6), FM% (SD) 39.4 (6.7). FMpp decreased compared to standard care −3.5 pp (95% CI −5.6 to −1.4) p=0.002, −6.3 pp (CI −8.4 to −4.1) p<0.001, and −8.0 pp (95% CI −10.2 to −5.8) p<0.001, for DCON, MED, and HED, respectively. The difference between HED and MED was −1.8 pp [95% CI −3.9 to 0.4]; p=0.11). CONCLUSIONS: All interventions were superior in reducing FMpp compared to standard care in a dose-dependent manner. Adding three or six sessions of exercise to a low-calorie diet was superior in reducing FM compared to a low-calorie diet alone. Article Highlights: Why did we undertake this study? Exercise and weight loss are recommended for persons with type 2 diabetes. It is unclear if adding exercise, and which amount of exercise, to a low-calorie diet supports additional fat mass loss. What is the specific question(s) we wanted to answer? What is the dose-response effect of exercise combined with a moderate caloric restriction on changes in fat mass? What did we find? Adding exercise to a diet-induced weight loss reduced fat mass and preserved fat-free mass in a dose-dependent manner. What are the implications of our findings? Adding exercise to a moderate caloric restriction dose-dependently facilitates reductions in fat mass by enlarging weight loss and fat loss.